5712 Results

People

  1. Drilon
    Drilon
  2. Perales
    Perales
  3. Giralt
    Giralt
  4. Motzer
    Motzer
  5. Ladanyi
    Ladanyi
  6. Morrow
    Morrow
  7. Rimner
    Rimner
  8. O'Reilly
    O'Reilly
  9. Horwitz
    Horwitz
  10. Jones
    Jones

Groups

  1. Department of Medicine (2534)
  2. Solid Tumor Oncology Division (1517)
  3. Sloan Kettering Institute Postdocs (1176)
  4. GSK Faculty (1088)
  5. Surgery (954)
  6. Survivorship Research (922)
  7. Hematologic Malignancies, Division of (875)
  8. Center for Hematologic Malignancies (802)
  9. Population Sciences Research Program (786)
  10. Department of Pathology and Laboratory Medicine (677)
  1. "2021"
Formats
  1. Journal Article (2507)
  2. Meeting Abstract (1731)
  3. Review (604)
  4. Editorial (358)
  5. Book Section (123)
  6. Correspondence (107)
  7. Guidelines (103)
  8. Research Letter (91)
  9. Miscellaneous (52)
  10. Conference Paper (34)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2534)
  2. Solid Tumor Oncology Division (1517)
  3. Sloan Kettering Institute Postdocs (1176)
  4. GSK Faculty (1088)
  5. Surgery (954)
  6. Survivorship Research (922)

More Groups

People
  1. Alexander Drilon (76)
  2. Miguel-Angel Perales (68)
  3. Sergio Giralt (66)
  4. Robert Motzer (65)
  5. Marc Ladanyi (62)
  6. Monica Morrow (57)

More People

Years
  1. 2021 (5712)
Publications
  1. Journal of Clinical Oncology (471)
  2. Blood (252)
  3. Annals of Oncology (148)
  4. Cancer Research (145)
  5. International Journal of Radiation Oncology, Biology, Physics (145)
  6. Journal of Thoracic Oncology (101)

More Publications

Publishers
  1. Elsevier Inc. (723)
  2. American Society of Clinical Oncology (522)
  3. Springer (381)
  4. Oxford University Press (360)
  5. Nature Publishing Group (344)
  6. American Association for Cancer Research (297)

More Publishers

Results (5712)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Quantitative change in metabolic tumor volume may assist in distinguishing between pseudoprogressors and responders in patients with relapsed/refractory classical Hodgkin lymphoma treated with PD-1 blockade
    Meeting Abstract

    Wills, B.; Michaud, L.; Schòˆder, H.; Ganesan, N.; Moskowitz, C. H.; Straus, D. J.; Falchi, L.; Matasar, M. J.; Zelenetz, A. D.; Joffe, E.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Outcomes of aggressive B cell lymphoma patients with no evidence of measurable disease at the time of CD19 chimeric antigen receptor T cell therapy: The experience from the CAR T Cell Consortium
    Meeting Abstract

    Wudhikarn, K.; Tomas, A. A.; Brower, J.; Bachanova, V.; Maziarz, R. T.; McGuirk, J. P.; Nastoupil, L.; Porter, D. L.; Riedell, P. A.; Perales, M. A.
    Blood (2021)

    Fulltext@MSK | Save
  • Combination of three unique anti-tumor modalities engineered into iPSC-derived T cells demonstrate a synergistic effect in overcoming tumor heterogeneity and cancer escape
    Meeting Abstract

    Yang, B. H.; Lin, Y. S. E.; Shirinbak, S.; Yeh, W. I.; Pribadi, M.; Chu, H. Y.; Gutierrez, A.; Mehta, A.; Avramis, E.; Petrovic, R.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • SRSF2-P95H delays myelofibrosis development through altered JAK/STAT signaling in JAK2(V617F) megakaryocytes
    Meeting Abstract

    Willekens, C.; Laplane, L.; Dagher, T.; Benlabiod, C.; Lacout, C.; Rameau, P.; Catelain, C.; Alfaro, A.; Edmond, V.; Signolle, N.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of extended use of romiplostim treatment for chemotherapy-induced thrombocytopenia
    Meeting Abstract

    Wilkins, C. R.; Ortiz, J.; Gilbert, L.; Yin, S.; Mones, J. V.; Parameswaran, R.; Mantha, S.; Soff, G. A.
    Blood (2021)

    Fulltext@MSK | Save
  • Impact of platelet transfusion on pulmonary function of hematology oncology patients: The Piper study
    Meeting Abstract

    Wheeler, A. P.; Snyder, E. L.; Refaai, M. A.; Cohn, C. S.; Poisson, J.; Fontaine, M. J.; Sehl, M.; Nooka, A. K.; Uhl, L.; Spinella, P. C.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Single-cell profiling reveals clinically relevant evolutionary trajectories and alternate biologies in human follicular lymphoma
    Meeting Abstract

    Wang, X.; Nissen, M.; Gracias, D.; Kusakabe, M.; Simkin, G.; Duns, G.; Sarkozy, C.; Chavez, E.; Segat, G. C.; Kim, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Metabolic tumor volume and total lesion glycolysis can predict response to very low dose radiotherapy (4 Gy) in indolent B-cell lymphomas
    Meeting Abstract

    Wijetunga, N. A.; Imber, B. S.; Lee, J.; Hajj, C.; Mayerhoefer, M. E.; Schoder, H.; Yahalom, J.
    Blood (2021)

    Fulltext@MSK | Save
  • Disease-modifying potential of bet inhibitor pelabresib (CPI-0610) as demonstrated by improvements in bone marrow function and clinical activity in patients with myelofibrosis - preliminary Data
    Meeting Abstract

    Verstovsek, S.; Salama, M. E.; Mascarenhas, J.; Talpaz, M.; Mesa, R. A.; Vannucchi, A.; Rampal, R.; Oh, S. T.; Olteanu, H.; Chiu, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Pirtobrutinib, a next generation, highly selective, non-covalent BTK inhibitor in previously treated mantle cell lymphoma: Updated results from the phase 1/2 BRUIN study
    Meeting Abstract

    Wang, M.; Shah, N. N.; Alencar, A. J.; Gerson, J. N.; Patel, M. R.; Fakhri, B.; Jurczak, W.; Tan, X. N.; Lewis, K.; Fenske, T. S.; more...
    Blood (2021)

    Fulltext@MSK | Save